Marc L. Citron

7.6k total citations · 2 hit papers
66 papers, 3.6k citations indexed

About

Marc L. Citron is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Marc L. Citron has authored 66 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 19 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Marc L. Citron's work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (11 papers) and Pain Management and Opioid Use (9 papers). Marc L. Citron is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (11 papers) and Pain Management and Opioid Use (9 papers). Marc L. Citron collaborates with scholars based in United States, Singapore and Switzerland. Marc L. Citron's co-authors include Constance Cirrincione, Daniel R. Budman, Clifford A. Hudis, Donald A. Berry, Eric P. Winer, I. Craig Henderson, Hyman B. Muss, Larry Norton, Steven D. Stellman and Daniel B. Yarosh and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marc L. Citron

65 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer

2006 518 citations Donald A. Berry, Constance Cirrincione et al. JAMA profile →
Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

2016 398 citations Judith A. Paice, Russell K. Portenoy et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Marc L. Citron

Since Specialization

Citations

This map shows the geographic impact of Marc L. Citron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc L. Citron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc L. Citron more than expected).

Fields of papers citing papers by Marc L. Citron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc L. Citron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc L. Citron. The network helps show where Marc L. Citron may publish in the future.

Co-authorship network of co-authors of Marc L. Citron

This figure shows the co-authorship network connecting the top 25 collaborators of Marc L. Citron. A scholar is included among the top collaborators of Marc L. Citron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc L. Citron. Marc L. Citron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline breakdown → 2016 ·Journal of Clinical Oncology ·Judith A. Paice, Russell K. Portenoy, Christina Lacchetti, Toby C. Campbell, Andrea Cheville, Marc L. Citron, Louis S. Constine, A. Cooper, Paul Glare, (unknown), Lakshmi Koyyalagunta, Michael Levy, Christine Miaskowski, Shirley Otis‐Green, Paul A. Sloan, Éduardo Bruera	398
2	Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance) 2015 ·JNCI Journal of the National Cancer Institute ·Jennifer A. Ligibel, Constance Cirrincione, Minetta C. Liu, Marc L. Citron, James N. Ingle, William J. Gradishar, Silvana Martino, William M. Sikov, Richard A. Michaelson, Elaine R. Mardis, Charles M. Perou, Matthew J. Ellis, Eric P. Winer, Clifford A. Hudis, Donald A. Berry, William T. Barry	44
3	Isolated Sternal Involvement in Breast Cancer: Is it Truly Stage IV Disease? 2011 ·Clinical Breast Cancer ·(unknown), Alan B. Astrow, Paula Klein, Yiwu Huang, Bonnie Reichman, Marc L. Citron	1
4	Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer 2006 ·Obstetrical & Gynecological Survey ·Donald A. Berry, Constance Cirrincione, I. Craig Henderson, Marc L. Citron, Daniel R. Budman, Lori J. Goldstein, Silvana Martino, Edith A. Perez, Hyman B. Muss, Larry Norton, Clifford A. Hudis, Eric P. Winer	24
5	Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer breakdown → 2006 ·JAMA ·Donald A. Berry, Constance Cirrincione, I. Craig Henderson, Marc L. Citron, Daniel R. Budman, Lori J. Goldstein, Silvana Martino, Edith A. Perez, Hyman B. Muss, Larry Norton, Clifford A. Hudis, Eric P. Winer	518
6	Dose Density in Adjuvant Chemotherapy for Breast Cancer 2004 ·Cancer Investigation ·Marc L. Citron	19
7	Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs 2003 ·Cancer ·Joshua Muscat, (unknown), John P. Richie, Nasser K. Altorki, Marc L. Citron, Sara H. Olson, Alfred I. Neugut, Steven D. Stellman	68
8	Long-Term Administration of Controlled-Release Oxycodone Tablets for the Treatment of Cancer Pain 1998 ·Cancer Investigation ·Marc L. Citron, (unknown), Winston C. V. Parris, (unknown), Laurel Herbst, Richard J. Rosenbluth, Robert F. Reder, (unknown), Barbara J. Buckley, Robert F. Kaiko	39
9	Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study 1998 ·European Journal of Pain ·(unknown), Barry S. Berman, Peter T. Silberstein, Marc L. Citron, Linda R. Bressler, Sharon M. Weinstein, Robert F. Kaiko, Barbara J. Buckley, Robert F. Reder	138
10	Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study. 1998 ·Journal of Clinical Oncology ·John H. Fetting, Robert J. Gray, Diane L. Fairclough, Thomas J. Smith, Kim Margolin, Marc L. Citron, (unknown), David Cella, K. J. Pandya, Nicholas J. Robert, I. Craig Henderson, C. Kent Osborne, Martin D. Abeloff	30
11	O6-Methylguanine-DNA Methyltransferase in Ovarian Malignancy and Its Correlation with Postoperative Response to Chemotherapy 1994 ·Gynecologic Oncology ·Sidney S. Chen, Marc L. Citron, Gregory Spiegel, Daniel B. Yarosh	15
12	Adjuvant Therapy for Breast Cancer 1994 ·Clinical Obstetrics & Gynecology ·Daniel R. Budman, Marc L. Citron	2
13	O⁶-Methylguanine-DNA Methyltransferase in Normal and Malignant Tissue of the Breast 1994 ·Cancer Investigation ·Marc L. Citron, (unknown), Hanna Rothenberg, Karen Kostroff, Patricia Wasserman, Leonard B. Kahn, A White, Gerard P. Burns, D. Held, Daniel B. Yarosh	21
14	A Phase II Trial of Concomitant Human Interleukin-2 and Interferon-??-2a in Patients with Disseminated Malignant Melanoma 1993 ·Journal of Immunotherapy ·Robert P. Whitehead, (unknown), Marc L. Citron, (unknown), Nancy P. Moldawer, Dilip Patel, (unknown), Dan Levitt, J. Zeffren	19
15	O⁶-Methylguanine-DNA Methyltransferase in Human Normal and Malignant Lung Tissues 1993 ·Cancer Investigation ·Marc L. Citron, (unknown), (unknown), Mark A. Hoffman, Mark P. Lewis, Patricia Wasserman, (unknown), Leonard B. Kahn, A White, Daniel B. Yarosh	16
16	Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study 1992 ·Cancer Investigation ·Marc L. Citron, Caron Modeas, Kathleen J. Propert, (unknown), Mark R. Green	12
17	Detection of Messenger RNA From O6-Methylguanine-DNA Methyltransferase Gene MGMT in Human Normal and Tumor Tissues 1992 ·JNCI Journal of the National Cancer Institute ·Marc L. Citron, (unknown), (unknown), (unknown), R. W. Decker, (unknown), Leonard B. Kahn, Anne White, Albert J. Fornace, Daniel B. Yarosh	40
18	Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer 1992 ·Cancer ·Jon R. Cohen, (unknown), Marc L. Citron	42
19	Non-Hodgkin's lymphoma during pregnancy 1991 ·Gynecologic Oncology ·Mark Spitzer, Marc L. Citron, Carl F. Ilardi, (unknown)	23
20	Clearance of Continuous Intravenous Morphine for Severe Cancer Pain 1987 ·Drug Intelligence & Clinical Pharmacy ·Marc L. Citron, J. R. Reynolds, (unknown), (unknown), (unknown), Martin H. Cohen, Steven H. Krasnow, (unknown), Vicki Seltzer	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact